Ferret Cytokine Panels

About Ampersand Biosciences

Ampersand Biosciences is a specialized provider of immunoassay solutions and services, leveraging deep expertise in the Luminex platform to support preclinical research in infectious diseases and immunology. Founded in 2019 (with operations beginning in 2016), the company has carved a niche by developing first-to-market cytokine panels for ferret and hamster models, which are critical for studying influenza, COVID-19, and other respiratory diseases. As a privately owned, grant-funded entity, it operates a hybrid business model combining product sales and contract services, targeting pharmaceutical companies and academic research labs. Its repeated success in securing SBIR grants underscores the innovative and needed nature of its work in filling gaps in preclinical research tools.

Therapeutic Areas